Castle Biosciences (CSTL) stock Forecast for 2021 – 2025

Castle Biosciences (CSTL) stock Forecast for 2022 – 2026

Last update: 05-24-2022, 9:14

Sector: Healthcare

The share price of Castle Biosciences, Inc. (CSTL) now

What analysts predict:: $48.29

52-week high/low: $78.92 / $17.01

50/200 Day Moving Average: $31.57 / $48.4

This figure corresponds to the average price over the previous 50/200 days. For Castle Biosciences stocks, the 50-day moving average is the resistance level today.

For Castle Biosciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences stock price in 2022, 2023, 2024, 2025, 2026. How much will one Castle Biosciences share be worth in 2022 - 2026?

When should I take profit in Castle Biosciences stock? When should I record a loss on Castle Biosciences stock? What are analysts' forecasts for Castle Biosciences stock? What is the future of Castle Biosciences stock?

We forecast Castle Biosciences stock performance using neural networks based on historical data on Castle Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Castle Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Castle Biosciences shares. This happens once a day.




Historical and forecast chart of Castle Biosciences stock

The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Castle Biosciences stock price can be found in the table below.

Long-term forecasts by years.

Castle Biosciences daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 22.53 21.92 22.89 4.44
May 27 22.10 21.86 22.76 4.12
May 28 21.50 21.11 21.94 3.91
May 29 21.89 21.37 22.30 4.34
May 30 21.76 21.28 22.19 4.30
May 31 22.61 21.91 23.13 5.57
Jun 01 22.72 22.37 23.12 3.37
Jun 02 22.94 22.48 23.52 4.61
Jun 03 22.53 21.81 23.24 6.57
Jun 04 22.88 22.60 23.33 3.24
Jun 05 22.93 22.35 23.62 5.70
Jun 06 23.39 22.87 23.83 4.21
Jun 07 23.21 22.83 23.86 4.51
Jun 08 23.08 22.66 23.39 3.22
Jun 09 23.43 23.16 24.03 3.76
Jun 10 24.28 24.02 24.81 3.28
Jun 11 24.76 24.24 25.55 5.39
Jun 12 25.72 25.31 26.42 4.39
Jun 13 25.14 24.54 25.61 4.39
Jun 14 24.47 23.73 25.15 5.98
Jun 15 24.16 23.57 24.78 5.17
Jun 16 23.54 22.81 24.03 5.32
Jun 17 23.72 23.34 24.10 3.29
Jun 18 24.11 23.43 24.49 4.53
Jun 19 24.74 24.21 24.97 3.15
Jun 20 24.67 24.42 25.37 3.88
Jun 21 25.00 24.35 25.78 5.87
Jun 22 24.04 23.46 24.26 3.40
Jun 23 23.18 22.87 23.75 3.85
Jun 24 23.25 22.56 23.54 4.37

Castle Biosciences Daily Price Targets


Castle Biosciences Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $22.53. Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.252%.

Pessimistic target level: 21.92

Optimistic target level: 22.89


Castle Biosciences Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $22.10. Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.961%.

Pessimistic target level: 21.86

Optimistic target level: 22.76


Castle Biosciences Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $21.50. Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.764%.

Pessimistic target level: 21.11

Optimistic target level: 21.94


Castle Biosciences Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $21.89. Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.162%.

Pessimistic target level: 21.37

Optimistic target level: 22.30


Castle Biosciences Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $21.76. Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 4.120%.

Pessimistic target level: 21.28

Optimistic target level: 22.19


Castle Biosciences Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $22.61. Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 5.278%.

Pessimistic target level: 21.91

Optimistic target level: 23.13


CSTL (CSTL) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 21.36 20.49 22.47 8.78
Jul. 23.51 21.31 24.40 12.68
Aug. 22.66 21.26 23.99 11.37
Sep. 20.22 18.21 22.08 17.56
Oct. 20.05 19.40 21.90 11.41
Nov. 19.18 17.38 20.12 13.61
Dec. 21.35 19.56 23.59 17.10

Castle Biosciences forecast for this year


Castle Biosciences Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $21.3614. Pessimistic: $20.49. Optimistic: $22.47


Castle Biosciences Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $23.5146. Pessimistic: $21.31. Optimistic: $24.40


Castle Biosciences Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $22.6587. Pessimistic: $21.26. Optimistic: $23.99


Castle Biosciences Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $20.2161. Pessimistic: $18.21. Optimistic: $22.08


Castle Biosciences Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $20.0462. Pessimistic: $19.40. Optimistic: $21.90


Castle Biosciences Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $19.1762. Pessimistic: $17.38. Optimistic: $20.12


Castle Biosciences Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $21.3508. Pessimistic: $19.56. Optimistic: $23.59




Castle Biosciences (CSTL) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 22.13 20.39 24.20 15.74
Feb 22.69 21.13 23.83 11.33
Mar 20.49 18.72 21.87 14.43
Apr 19.69 18.12 21.10 14.11
May 17.02 15.25 18.18 16.11
Jun 16.06 14.40 17.77 18.98
Jul 15.30 13.86 16.24 14.64
Aug 15.13 13.71 16.25 15.64
Sep 16.12 14.81 17.34 14.58
Oct 17.16 16.08 18.60 13.56
Nov 19.28 18.49 20.41 9.39
Dec 19.65 18.50 21.08 12.27

Castle Biosciences (CSTL) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 19.13 17.23 19.67 12.39
Feb 19.77 18.80 20.41 7.87
Mar 18.42 16.48 19.35 14.79
Apr 18.00 17.30 20.00 13.49
May 17.98 16.57 19.39 14.54
Jun 17.63 16.05 18.76 14.47
Jul 17.95 15.94 19.83 19.64
Aug 18.80 18.25 19.75 7.60
Sep 17.51 17.00 19.01 10.58
Oct 18.00 16.06 18.88 14.95
Nov 19.06 17.11 20.82 17.81
Dec 19.25 17.12 20.14 14.99



Castle Biosciences (CSTL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 21.57 19.66 23.38 15.89
Feb 23.53 21.26 26.00 18.24
Mar 22.08 20.56 23.13 11.09
Apr 23.53 22.31 25.08 11.03
May 24.03 23.08 24.70 6.54
Jun 23.25 22.34 25.08 10.90
Jul 22.60 21.90 24.40 10.24
Aug 24.12 22.33 24.86 10.19
Sep 23.17 21.84 24.02 9.05
Oct 24.60 23.50 26.94 12.78
Nov 24.74 22.07 27.48 19.66
Dec 24.84 23.42 25.89 9.54

Castle Biosciences (CSTL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 23.73 22.90 24.83 7.76
Feb 25.36 22.87 26.81 14.70
Mar 27.03 24.15 28.35 14.81
Apr 28.84 26.50 30.86 14.13
May 29.93 26.96 32.78 17.77
Jun 32.41 30.00 35.72 16.00
Jul 34.81 32.62 37.05 11.97
Aug 38.37 35.31 41.64 15.22
Sep 38.80 35.86 43.09 16.77
Oct 38.09 35.16 40.86 13.96
Nov 35.80 33.04 38.76 14.74
Dec 37.00 35.91 39.18 8.33

Castle Biosciences information and performance

Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization: 486 877 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 5 935 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.044

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.926

Quarterly Revenue Growth YOY: 0.177

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.319

Enterprise Value (EV) /Revenue

EV To EBITDA: 11562.57

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 26260900

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.